It's a development that marks a major step forward for patients struggling with moderate-to-severe chronic spontaneous urticaria
Globally, Abbott has received reports of 736 severe adverse events linked to the issue, including seven deaths (none in the US)
The European Commission’s green light marks Breyanzi’s fourth indication in Europe and extends access to patients across all EU and EEA countries
Jaypirca is making waves in the fight against B-cell malignancies
Elevidys came under scrutiny in June when the FDA disclosed two fatal cases in non-ambulatory boys who developed dangerously high liver enzyme levels
The non-dilutive financing includes three tranches
Call it a major milestone in bladder cancer therapy that aims to provide a lifeline for patients who previously had limited options
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
Millions of stroke survivors across the world may soon have a new defense
Paxton alleges the companies marketed Plavix as a reliable defense against heart attacks, strokes, and blood clots while failing to disclose evidence that the drug could be ineffective or virtually useless for many people
Subscribe To Our Newsletter & Stay Updated
